POST- ACUTE CARE
Joel Ackerman has been named CFO of DaVita, effective March 1. He replaces Jim Hilger, who has served as the company’s interim CFO since 2015. Hilger will resume his role as chief accounting officer, a position he has held since 2010.
Ackerman, 51, is currently CEO of Champions Oncology, a company that provides technology solutions to personalize the development and use of oncology drugs.